BioClinica®, Inc.,a global provider of clinical trial management services, announced today that Mundipharma Research, a dynamic pharmaceutical research and development company has selected BioClinica’s OnPoint CTMS (Clinical Trial Management System). With this decision, Mundipharma Research plans to utilize OnPoint CTMS for various aspects of its clinical trial management activity.
Mundipharma Research selected OnPoint CTMS for its highly adaptive design that complements the company’s approach to pharmaceutical development. OnPoint CTMS is a powerful end-to-end clinical trial management solution that brings improvements in control and efficiency of clinical trials. As a web-based CTMS, it gives sponsors the ability to view and manage real-time operational performance – wherever and whenever.
OnPoint’s Office-Smart capabilities enhance Mundipharma Research’s existing investment in Microsoft technologies by letting users access, update, and report on clinical trial data from within the familiar environment of Microsoft Office and SharePoint. Using SharePoint as a collaborative portal, OnPoint’s web services integration with other trial management products provides an end-to-end trial management solution. This approach greatly enhances user adoption, and helps avoid the pitfalls of less adaptive CTMS products.
“We are very excited about Mundipharma Research’s decision to utilize the OnPoint approach to clinical trial management,” said Peter Benton, President of BioClinica’s eClinical Solutions. “Mundipharma Research is known for being a dynamic organization wholly dedicated to the research and development of highly effective and innovative medications. This requires supporting technologies that empowers users and makes them more productive. OnPoint’s customizable structure and robust reporting capabilities will accomplish this for Mundipharma Research while increasing collaboration and visibility.”
BioClinica will be hosting its first BioClinica European User Conference on February 26th 2014 in Cologne, Germany. Follow BioClinica on the Trial Blazers blog at http://www.bioclinica.com/blog and on twitter at http://twitter.com/bioclinica.
Original Press Release: http://www.bioclinica.com/news-events/press-releases/mundipharma-research-becomes-latest-pharmaceutical-company-choose